Table 1.
Baseline clinical features of the resolved and recurrent groups.
| Findings | Resolved Group (n = 24) | Recurrent Group (n = 23) | p Value |
|---|---|---|---|
| Age (years) | 63.4 ± 11.8 ‡ | 67.0 ± 7.2 ‡ | 0.213 |
| Gender (female/male) | 16/8 | 11/12 | 0.192 |
| Duration of macular edema (days) | 45.7 ± 29.0 ‡ | 39.1 ± 15.8 ‡ | 0.338 |
| Hypertension | 15 | 19 | 0.123 |
| Systolic Blood pressure (mmHg) | 139 ± 18 | 144 ± 13 | 0.284 |
| Diastolic Blood pressure (mmHg) | 83 ± 13 | 87 ± 10 | 0.239 |
| Hyperlipidemia | 10 | 12 | 0.471 |
| Baseline BCVA (logMAR) | 0.44 ± 0.40 ‡ | 0.46 ± 0.36 ‡ | 0.806 |
| Baseline CMT (μm) | 611 ± 211 ‡ | 666 ± 194 ‡ | 0.353 |
| MBP (mmHg) | 102 ± 13 ‡ | 106 ± 9.9 ‡ | 0.191 |
| OPP (mmHg) | 54 ± 9.1 ‡ | 57 ± 6.4 ‡ | 0.240 |
BCVA = best-corrected visual acuity; CMT = central macular thickness; log MAR = logarithm of the minimum angle of resolution; MBP = mean blood pressure; OPP = ocular perfusion pressure; ‡ Mean ± standard deviation (SD).